Component
Adenylyl cyclase catalytic activity, model specified
Adenylyl cyclase catalytic activity, model specified. Species, exposure and limitations are retained in each linked claim.
8 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
The biochemistry of the cannabinoid inhibition of adenylate cyclase in neuroblastoma membranes showed the response to be guanine-nucleotide dependent.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/thc-research/2984538.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e1ac047a734fcf178fc62cc2e117533f5ebc2b0779132c0315d3d954c4c728e5", "start_char": 0, "end_char": 1743, "text_sha256": "e1ac047a734fcf178fc62cc2e117533f5ebc2b0779132c0315d3d954c4c728e5"}
- experimental_model
- Biochemistry of the cannabinoid adenylate cyclase response in neuroblastoma membranes
- exposure
- Guanine nucleotide dependence of the response
- limitations
- The biochemical companion paper establishing G-protein dependence.
- nutrient_topic
- THC research collection; topical membership is not evidence of a direct clinical effect, and THC is recorded separately from the endocannabinoids it imitates. · Delta-9-tetrahydrocannabinol / THC
- organism
- Cultured neuroblastoma cells
- plain_language
- The inhibition runs through a G protein, as a receptor response should.
- primary_references
- [thc-p2984538] Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes. (1985). https://pubmed.ncbi.nlm.nih.gov/2984538/ DOI: 10.1016/s0026-895x(25)12377-8
- tissue_or_cell_type
- Cell membranes
THC: the cannabinoid receptors, the endocannabinoid system it occupies, what the drug does, and the dietary fat it is built from (2026-09-21) · lines 166–177
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Biochemistry of the cannabinoid adenylate cyclase response in neuroblastoma membranes · source_derived_draft · unverified_draft
### thc-ac-inhibition-biochemistry The biochemistry of the cannabinoid inhibition of adenylate cyclase in neuroblastoma membranes showed the response to be guanine-nucleotide dependent. Condition category: normal nutrient_topic: THC research collection; topical membership is not evidence of a direct clinical effect, and THC is recorded separately from the endocannabinoids it imitates. plain_language: The inhibition runs through a G protein, as a receptor response should. organism: Cultured neuroblastoma cells tissue_or_cell_type: Cell membranes experimental_model: Biochemistry of the cannabinoid adenylate cyclase response in neuroblastoma membranes limitations: The biochemical companion paper establishing G-protein dependence. exposure: Guanine nucleotide dependence of the response evidence_span: {"source_cache": "artifacts/thc-research/2984538.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e1ac047a734fcf178fc62cc2e117533f5ebc2b0779132c0315d3d954c4c728e5", "start_char": 0, "end_char": 1743, "text_sha256": "e1ac047a734fcf178fc62cc2e117533f5ebc2b0779132c0315d3d954c4c728e5"} [thc-p2984538] Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes. (1985). https://pubmed.ncbi.nlm.nih.gov/2984538/ DOI: 10.1016/s0026-895x(25)12377-8
Complete structured claim and evidenceAnandamide interacted specifically with cannabinoid receptors and inhibited adenylate cyclase, reproducing the signature response of the plant cannabinoids.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/thc-research/8515284.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "36a5b1eec5097dbdfd0224629f4d8449f8688d0476820823ffcbe3b92d68c66d", "start_char": 0, "end_char": 1015, "text_sha256": "36a5b1eec5097dbdfd0224629f4d8449f8688d0476820823ffcbe3b92d68c66d"}
- experimental_model
- Receptor binding and adenylate cyclase assays with anandamide
- exposure
- Anandamide against cannabinoid receptors and cyclase
- limitations
- Confirms the endogenous ligand reproduces the receptor signature of the drug.
- nutrient_topic
- THC research collection; topical membership is not evidence of a direct clinical effect, and THC is recorded separately from the endocannabinoids it imitates. · Delta-9-tetrahydrocannabinol / THC
- organism
- Rat brain preparations
- plain_language
- The natural ligand does the same thing to the same enzyme as the drug.
- primary_references
- [thc-p8515284] Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. (1993). https://pubmed.ncbi.nlm.nih.gov/8515284/ DOI: 10.1111/j.1471-4159.1993.tb03576.x
- tissue_or_cell_type
- Brain membranes
THC: the cannabinoid receptors, the endocannabinoid system it occupies, what the drug does, and the dietary fat it is built from (2026-09-21) · lines 257–268
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Receptor binding and adenylate cyclase assays with anandamide · source_derived_draft · unverified_draft
### thc-anandamide-inhibits-cyclase Anandamide interacted specifically with cannabinoid receptors and inhibited adenylate cyclase, reproducing the signature response of the plant cannabinoids. Condition category: normal nutrient_topic: THC research collection; topical membership is not evidence of a direct clinical effect, and THC is recorded separately from the endocannabinoids it imitates. plain_language: The natural ligand does the same thing to the same enzyme as the drug. organism: Rat brain preparations tissue_or_cell_type: Brain membranes experimental_model: Receptor binding and adenylate cyclase assays with anandamide limitations: Confirms the endogenous ligand reproduces the receptor signature of the drug. exposure: Anandamide against cannabinoid receptors and cyclase evidence_span: {"source_cache": "artifacts/thc-research/8515284.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "36a5b1eec5097dbdfd0224629f4d8449f8688d0476820823ffcbe3b92d68c66d", "start_char": 0, "end_char": 1015, "text_sha256": "36a5b1eec5097dbdfd0224629f4d8449f8688d0476820823ffcbe3b92d68c66d"} [thc-p8515284] Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. (1993). https://pubmed.ncbi.nlm.nih.gov/8515284/ DOI: 10.1111/j.1471-4159.1993.tb03576.x
Complete structured claim and evidenceCannabinoids inhibited adenylate cyclase in neuroblastoma cell membranes with a pharmacology matching their psychoactivity.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/thc-research/6092901.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "996df269d90c0b0e02d12157d4ebc3dd16e6be5013bc741cf4ed9b798f0e7eb5", "start_char": 0, "end_char": 1329, "text_sha256": "996df269d90c0b0e02d12157d4ebc3dd16e6be5013bc741cf4ed9b798f0e7eb5"}
- experimental_model
- Cannabinoid pharmacology of adenylate cyclase in neuroblastoma cell membranes
- exposure
- Cannabinoid concentration-response on adenylate cyclase
- limitations
- One of the two founding pharmacology papers for Gi coupling. A transformed cell line, and cAMP is a proximal readout.
- nutrient_topic
- THC research collection; topical membership is not evidence of a direct clinical effect, and THC is recorded separately from the endocannabinoids it imitates. · Delta-9-tetrahydrocannabinol / THC
- organism
- Cultured neuroblastoma cells
- plain_language
- The drug turns down the enzyme that makes the cell’s main second messenger.
- primary_references
- [thc-p6092901] Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. (1984). https://pubmed.ncbi.nlm.nih.gov/6092901/ DOI: 10.1016/s0026-895x(25)15066-9
- tissue_or_cell_type
- Cell membranes
THC: the cannabinoid receptors, the endocannabinoid system it occupies, what the drug does, and the dietary fat it is built from (2026-09-21) · lines 153–164
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cannabinoid pharmacology of adenylate cyclase in neuroblastoma cell membranes · source_derived_draft · unverified_draft
### thc-cannabinoid-inhibits-ac Cannabinoids inhibited adenylate cyclase in neuroblastoma cell membranes with a pharmacology matching their psychoactivity. Condition category: normal nutrient_topic: THC research collection; topical membership is not evidence of a direct clinical effect, and THC is recorded separately from the endocannabinoids it imitates. plain_language: The drug turns down the enzyme that makes the cell’s main second messenger. organism: Cultured neuroblastoma cells tissue_or_cell_type: Cell membranes experimental_model: Cannabinoid pharmacology of adenylate cyclase in neuroblastoma cell membranes limitations: One of the two founding pharmacology papers for Gi coupling. A transformed cell line, and cAMP is a proximal readout. exposure: Cannabinoid concentration-response on adenylate cyclase evidence_span: {"source_cache": "artifacts/thc-research/6092901.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "996df269d90c0b0e02d12157d4ebc3dd16e6be5013bc741cf4ed9b798f0e7eb5", "start_char": 0, "end_char": 1329, "text_sha256": "996df269d90c0b0e02d12157d4ebc3dd16e6be5013bc741cf4ed9b798f0e7eb5"} [thc-p6092901] Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. (1984). https://pubmed.ncbi.nlm.nih.gov/6092901/ DOI: 10.1016/s0026-895x(25)15066-9
Complete structured claim and evidenceA cloned complementary DNA encoded a G protein-coupled receptor that inhibits adenylate cyclase in a dose-dependent, stereoselective and pertussis-toxin-sensitive manner, is more responsive to psychoactive than to non-psychoactive cannabinoids, and whose messenger RNA is found in the brain regions that have cannabinoid receptors.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/thc-research/2165569.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8d92b7104006ccc194ab498aa8f559606353e6ccc4b5aa7af0a9502c9bfc37db", "start_char": 0, "end_char": 1256, "text_sha256": "8d92b7104006ccc194ab498aa8f559606353e6ccc4b5aa7af0a9502c9bfc37db"}
- experimental_model
- Cloning and heterologous expression of a complementary DNA from rat brain
- exposure
- Cannabinoid binding and adenylate cyclase inhibition in the transfected cells
- limitations
- The founding cloning paper. It establishes a receptor, which is what displaced the membrane-disruption explanation of cannabinoid action.
- nutrient_topic
- THC research collection; topical membership is not evidence of a direct clinical effect, and THC is recorded separately from the endocannabinoids it imitates. · Delta-9-tetrahydrocannabinol / THC
- organism
- Rat receptor expressed in cells
- plain_language
- Cannabis acts on a specific receptor, not by melting cell membranes as was assumed.
- primary_references
- [thc-p2165569] Structure of a cannabinoid receptor and functional expression of the cloned cDNA. (1990). https://pubmed.ncbi.nlm.nih.gov/2165569/ DOI: 10.1038/346561a0
- tissue_or_cell_type
- Brain and neural cell lines
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cloning and heterologous expression of a complementary DNA from rat brain · source_derived_draft · unverified_draft
### thc-cb1-cloned A cloned complementary DNA encoded a G protein-coupled receptor that inhibits adenylate cyclase in a dose-dependent, stereoselective and pertussis-toxin-sensitive manner, is more responsive to psychoactive than to non-psychoactive cannabinoids, and whose messenger RNA is found in the brain regions that have cannabinoid receptors. Condition category: normal nutrient_topic: THC research collection; topical membership is not evidence of a direct clinical effect, and THC is recorded separately from the endocannabinoids it imitates. plain_language: Cannabis acts on a specific receptor, not by melting cell membranes as was assumed. organism: Rat receptor expressed in cells tissue_or_cell_type: Brain and neural cell lines experimental_model: Cloning and heterologous expression of a complementary DNA from rat brain limitations: The founding cloning paper. It establishes a receptor, which is what displaced the membrane-disruption explanation of cannabinoid action. exposure: Cannabinoid binding and adenylate cyclase inhibition in the transfected cells evidence_span: {"source_cache": "artifacts/thc-research/2165569.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8d92b7104006ccc194ab498aa8f559606353e6ccc4b5aa7af0a9502c9bfc37db", "start_char": 0, "end_char": 1256, "text_sha256": "8d92b7104006ccc194ab498aa8f559606353e6ccc4b5aa7af0a9502c9bfc37db"} [thc-p2165569] Structure of a cannabinoid receptor and functional expression of the cloned cDNA. (1990). https://pubmed.ncbi.nlm.nih.gov/2165569/ DOI: 10.1038/346561a0
Complete structured claim and evidenceCB1 and CB2 receptors were characterised for expression and adenylate cyclase modulation within the immune system.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/thc-research/9070350.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "ee1863096eec8d8a18cd47cbc858ebaba4cf13d8bb3b78cd5179e1c1200c130c", "start_char": 0, "end_char": 2231, "text_sha256": "ee1863096eec8d8a18cd47cbc858ebaba4cf13d8bb3b78cd5179e1c1200c130c"}
- experimental_model
- Expression and adenylate cyclase modulation across immune cell populations
- exposure
- Cannabinoid agonists with cAMP measurement
- limitations
- Maps which immune cells carry which receptor. Expression and cAMP modulation are measured; immune function outcomes are not.
- nutrient_topic
- THC research collection; topical membership is not evidence of a direct clinical effect, and THC is recorded separately from the endocannabinoids it imitates. · Delta-9-tetrahydrocannabinol / THC
- organism
- Mouse and human immune cells
- plain_language
- Immune cells carry the second receptor and respond through the same messenger.
- primary_references
- [thc-p9070350] Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. (1997). https://pubmed.ncbi.nlm.nih.gov/9070350/ DOI: 10.1006/taap.1996.8034
- tissue_or_cell_type
- Immune system
THC: the cannabinoid receptors, the endocannabinoid system it occupies, what the drug does, and the dietary fat it is built from (2026-09-21) · lines 101–112
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Expression and adenylate cyclase modulation across immune cell populations · source_derived_draft · unverified_draft
### thc-cb2-immune CB1 and CB2 receptors were characterised for expression and adenylate cyclase modulation within the immune system. Condition category: normal nutrient_topic: THC research collection; topical membership is not evidence of a direct clinical effect, and THC is recorded separately from the endocannabinoids it imitates. plain_language: Immune cells carry the second receptor and respond through the same messenger. organism: Mouse and human immune cells tissue_or_cell_type: Immune system experimental_model: Expression and adenylate cyclase modulation across immune cell populations limitations: Maps which immune cells carry which receptor. Expression and cAMP modulation are measured; immune function outcomes are not. exposure: Cannabinoid agonists with cAMP measurement evidence_span: {"source_cache": "artifacts/thc-research/9070350.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "ee1863096eec8d8a18cd47cbc858ebaba4cf13d8bb3b78cd5179e1c1200c130c", "start_char": 0, "end_char": 2231, "text_sha256": "ee1863096eec8d8a18cd47cbc858ebaba4cf13d8bb3b78cd5179e1c1200c130c"} [thc-p9070350] Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. (1997). https://pubmed.ncbi.nlm.nih.gov/9070350/ DOI: 10.1006/taap.1996.8034
Complete structured claim and evidenceThe sheep MT1 receptor inhibited adenylyl cyclase through a pertussis-toxin-sensitive mechanism in transfected cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/melatonin-research/7946354.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "4eed36768519d1c02ed67434eb3dc08eb561de445d3532113e7eaeb2827e021f", "start_char": 0, "end_char": 1054, "text_sha256": "4eed36768519d1c02ed67434eb3dc08eb561de445d3532113e7eaeb2827e021f"}
- experimental_model
- Receptor cloning, radioligand binding and functional expression
- exposure
- Heterologous COS-7 binding and NIH3T3 functional assays
- limitations
- Species differ across experiments. High-affinity radioligand binding is separated from the sheep functional assay.
- nutrient_topic
- Melatonin research collection; topical membership is not evidence of a direct dietary effect. · Melatonin
- organism
- Human and sheep MT1 in cells; functional cyclase assay used sheep receptor
- plain_language
- The receptor connects to an inhibitory signaling system.
- primary_references
- [melatonin-p7946354] Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. (1994). https://pubmed.ncbi.nlm.nih.gov/7946354/ DOI: 10.1016/0896-6273(94)90055-8
- tissue_or_cell_type
- Melatonin receptor identification
Melatonin: synthesis, receptors, circadian timing and nutrient interactions (2026-09-17) · lines 370–381
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Receptor cloning, radioligand binding and functional expression · source_derived_draft · unverified_draft
### melatonin-mt1-sheep-cyclase The sheep MT1 receptor inhibited adenylyl cyclase through a pertussis-toxin-sensitive mechanism in transfected cells. Condition category: normal nutrient_topic: Melatonin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The receptor connects to an inhibitory signaling system. organism: Human and sheep MT1 in cells; functional cyclase assay used sheep receptor tissue_or_cell_type: Melatonin receptor identification experimental_model: Receptor cloning, radioligand binding and functional expression limitations: Species differ across experiments. High-affinity radioligand binding is separated from the sheep functional assay. exposure: Heterologous COS-7 binding and NIH3T3 functional assays evidence_span: {"source_cache": "artifacts/melatonin-research/7946354.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "4eed36768519d1c02ed67434eb3dc08eb561de445d3532113e7eaeb2827e021f", "start_char": 0, "end_char": 1054, "text_sha256": "4eed36768519d1c02ed67434eb3dc08eb561de445d3532113e7eaeb2827e021f"} [melatonin-p7946354] Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. (1994). https://pubmed.ncbi.nlm.nih.gov/7946354/ DOI: 10.1016/0896-6273(94)90055-8
Complete structured claim and evidenceHuman MT2 expression supported melatonin-receptor-mediated inhibition of adenylyl cyclase.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/melatonin-research/7568007.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1873168e5fa570a1dec0bc112045a3bcffda494e92b52f3349c8b1afebbb505f", "start_char": 0, "end_char": 1269, "text_sha256": "1873168e5fa570a1dec0bc112045a3bcffda494e92b52f3349c8b1afebbb505f"}
- experimental_model
- Human receptor cloning and functional expression
- exposure
- Radioligand binding and adenylyl cyclase measurements
- limitations
- Receptor overexpression system; no claim a given oral dose produces the same occupancy in every human tissue.
- nutrient_topic
- Melatonin research collection; topical membership is not evidence of a direct dietary effect. · Melatonin
- organism
- Human MT2 expressed in COS-1 and NIH3T3 cells
- plain_language
- The second receptor can also reduce the signal that generates cAMP.
- primary_references
- [melatonin-p7568007] Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. (1995). https://pubmed.ncbi.nlm.nih.gov/7568007/ DOI: 10.1073/pnas.92.19.8734
- tissue_or_cell_type
- Second melatonin receptor subtype
Melatonin: synthesis, receptors, circadian timing and nutrient interactions (2026-09-17) · lines 383–394
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human receptor cloning and functional expression · source_derived_draft · unverified_draft
### melatonin-mt2-cyclase Human MT2 expression supported melatonin-receptor-mediated inhibition of adenylyl cyclase. Condition category: normal nutrient_topic: Melatonin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The second receptor can also reduce the signal that generates cAMP. organism: Human MT2 expressed in COS-1 and NIH3T3 cells tissue_or_cell_type: Second melatonin receptor subtype experimental_model: Human receptor cloning and functional expression limitations: Receptor overexpression system; no claim a given oral dose produces the same occupancy in every human tissue. exposure: Radioligand binding and adenylyl cyclase measurements evidence_span: {"source_cache": "artifacts/melatonin-research/7568007.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1873168e5fa570a1dec0bc112045a3bcffda494e92b52f3349c8b1afebbb505f", "start_char": 0, "end_char": 1269, "text_sha256": "1873168e5fa570a1dec0bc112045a3bcffda494e92b52f3349c8b1afebbb505f"} [melatonin-p7568007] Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. (1995). https://pubmed.ncbi.nlm.nih.gov/7568007/ DOI: 10.1073/pnas.92.19.8734
Complete structured claim and evidence
Where it participates (unsigned role)
UCP1 expression could be induced by any of the beta-1, beta-2 or beta-3 adrenergic receptor subtypes, but the greatest response came from stimulating all three simultaneously, and beta-3 stimulation did not prevent norepinephrine from further raising adenylyl cyclase activity, suggesting an additive cAMP response.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/cold-research/7738011.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b1c5506f21f40d6674727a5fc3344f2b02f7fc9f2f1e911fd04bfecfc2399175", "start_char": 0, "end_char": 2592, "text_sha256": "b1c5506f21f40d6674727a5fc3344f2b02f7fc9f2f1e911fd04bfecfc2399175"}
- experimental_model
- Immortalized mouse brown adipocyte cell lines with selective beta-adrenergic agonists and antagonists
- exposure
- Norepinephrine, the beta-3 selective agonist CL316,243, and subtype-selective antagonists
- limitations
- A cell-line dissection of receptor subtypes. The additive cAMP response indicates the subtypes are not redundant, but these are immortalized cells.
- nutrient_topic
- Cold water immersion research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake. · Cold water immersion
- organism
- Mouse cell lines
- plain_language
- Three different receptors for the same messenger all feed the heat gene, and together they do more than any one alone.
- primary_references
- [cold-p7738011] Regulation of the uncoupling protein gene (Ucp) by beta 1, beta 2, and beta 3-adrenergic receptor subtypes in immortalized brown adipose cell lines. (1995). https://pubmed.ncbi.nlm.nih.gov/7738011/ DOI: 10.1074/jbc.270.18.10723
- tissue_or_cell_type
- Brown adipocytes
Cold water immersion: cold sensing, heat production, the catecholamine axis and what repeated exposure changes (2026-09-19) · lines 364–375
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Immortalized mouse brown adipocyte cell lines with selective beta-adrenergic agonists and antagonists · source_derived_draft · unverified_draft
### cold-beta-receptors-ucp1 UCP1 expression could be induced by any of the beta-1, beta-2 or beta-3 adrenergic receptor subtypes, but the greatest response came from stimulating all three simultaneously, and beta-3 stimulation did not prevent norepinephrine from further raising adenylyl cyclase activity, suggesting an additive cAMP response. Condition category: normal nutrient_topic: Cold water immersion research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake. plain_language: Three different receptors for the same messenger all feed the heat gene, and together they do more than any one alone. organism: Mouse cell lines tissue_or_cell_type: Brown adipocytes experimental_model: Immortalized mouse brown adipocyte cell lines with selective beta-adrenergic agonists and antagonists limitations: A cell-line dissection of receptor subtypes. The additive cAMP response indicates the subtypes are not redundant, but these are immortalized cells. exposure: Norepinephrine, the beta-3 selective agonist CL316,243, and subtype-selective antagonists evidence_span: {"source_cache": "artifacts/cold-research/7738011.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b1c5506f21f40d6674727a5fc3344f2b02f7fc9f2f1e911fd04bfecfc2399175", "start_char": 0, "end_char": 2592, "text_sha256": "b1c5506f21f40d6674727a5fc3344f2b02f7fc9f2f1e911fd04bfecfc2399175"} [cold-p7738011] Regulation of the uncoupling protein gene (Ucp) by beta 1, beta 2, and beta 3-adrenergic receptor subtypes in immortalized brown adipose cell lines. (1995). https://pubmed.ncbi.nlm.nih.gov/7738011/ DOI: 10.1074/jbc.270.18.10723
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.